Silver Book Fact

“If you had been diagnosed with chronic myeloid leukemia (CML) in 1999, chances were that you would not be alive today. Just 3 out of 10 patients survived for even five years. In the meantime, you had two daunting treatment options: a high-risk bone marrow transplant or daily injections of interferon, the side effects of which have been compared to ‘having a bad case of the flu every day of your life.'”

Now “[y]ou can take a daily pill that has a good chance of driving your cancer into remission–normalizing your blood count with few, if any, side effects. The new medicine targets CML on a molecular level, so it affects only the enzyme responsible for the disease. The tremendous effectivenss and precision of the approach is heralded as the ‘wave of the future.'”

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A one percent reduction in lung, colorectal, breast, leukemia, pancreatic, and brain cancer mortality would reduce productivity costs by $814 million per year.  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • Surgical biopsy for lumps in the breast was found by one study to cost 2 1/2 to 3 times more than image-guided core-needle biopsy ($698 versus $243).  
  • FDA approved cancer advances
     
  • A modest decrease of 1% in cancer mortality has been estimated to be worth $500 billion in social value.